Abercrombie George B
- SEC CIK
- 0001485939
No open-market purchases or sales filed in the past year.
Current role at each company
- BCRX Biocryst Pharmaceuticals IncDirectoras of Jun 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Abercrombie George B as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2022 (view filing) | Apr 18 | 2 days | Abercrombie George BDirector | SSale | −5.00K | $11.04 | −$55.2K | −100.0%0 after | |
| Feb 16, 2022 (view filing) | Feb 15 | 1 day | Abercrombie George BDirector | SSale | −5.00K | $18.50 | −$92.5K | −100.0%0 after | |
| Nov 17, 2021 (view filing) | Nov 15 | 2 days | Abercrombie George BDirector | SSale | −5.00K | $12.27 | −$61.4K | −100.0%0 after | |
| Sep 17, 2021 (view filing) | Sep 15 | 2 days | Abercrombie George BDirector | SSale | −5.00K | $15.06 | −$75.3K | −100.0%0 after | |
| Sep 14, 2021 (view filing) | Sep 10 | 4 days | Abercrombie George BDirector | SSale | −74.0K | $15.09 | −$1.12M | −100.0%0 after | |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | Abercrombie George BDirector | SSale | −5.00K | $15.69 | −$78.5K | −62.5%3.00K after |